GoHealth shares jump 14.78% after-hours as $40M loan and strategic focus on retention, SNP growth signal improved liquidity and long-term stability.

GoHealth surged 14.78% in after-hours trading following its Q3 2025 earnings report, which highlighted a 2142.9% net loss and 71.1% revenue decline amid strategic Medicare Advantage market shifts. While the results signaled financial strain, management emphasized long-term value creation through cost discipline, retention focus, and Special Needs Plan (SNP) expansion. The announcement of a $40 million superpriority term loan to strengthen liquidity further bolstered investor confidence, offsetting prior concerns over sustained losses. CEO Vijay Kotte’s emphasis on platform efficiency and market stabilization aligned with the stock’s positive after-hours reaction, as investors interpreted the strategic pivot and liquidity measures as steps toward operational recovery.